Be Prepared to Treat Multidrug-Resistant "ESBL" and "CRE" Infections

April 2017

You'll hear more about treating "superbugs" such as ESBL and CRE...due to a push from the World Health Organization.

Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are popping up everywhere. And most states are reporting carbapenem-resistant Enterobacteriaceae (CRE)...which is fatal in about 50% of cases.

Help prevent progression of superbugs with judicious antibiotic use.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Infectious Diseases Be Prepared to Treat Multidrug-Resistant "ESBL" and "CRE" Infections
Surgery Help Optimize Peri-Op Antifibrinolytic Use to Reduce Blood Transfusions
Nephrology Lean Toward Trying Urea Before "Vaptans" for Hyponatremia
Heart Failure Focus on BP Control in Heart Failure Patients With Preserved Ejection Fraction
Fall Risk Be Sure Your Facility Uses a Fall-Risk Medication Assessment
New Drugs Don't Expect the Constipation Med Plecanatide (Trulance) to Be on Your Formulary
Neurology & Pain Ask Patients on Pramipexole or Ropinirole About Worsening Restless Legs Syndrome
Antithrombotics Limit Bleeding Risk in Patients Who Need an Anticoagulant Plus Antiplatelets
Constipation Help Parents With Concerns About Miralax and Neuropsych Effects in Children
Topicals Help Prescribers Choose Between Different Topical Dosage Forms
Neuromuscular Start With Baclofen or Gabapentin for Persistent Hiccups
Hepatitis C Put Warnings About Liver Damage With Hep C Meds Into Perspective

Be Prepared to Treat Multidrug-Resistant "ESBL" and "CRE" Infections

Get unlimited access through an Enterprise license

Table of Contents